Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

A Comprehensive Review of Medicarpin: A Phytoalexin with Therapeutic Potential

Tanimoto MH., de Miranda AM., Aldana-Mejía JA., de Araújo LS., de Freitas Pinheiro AM., Trindade AFG.

Narrative Review on Chronic Inflammation, published in ACS Omega (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
ACS Omega (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41280807
PMCID
PMC12631411
DOI
10.1021/acsomega.5c08170
Citations
1

Abstract (original English)

Initially, research on medicarpin focused on its role in crop protection, including gene modifications, allelopathic effects, antifungal potential, and biosynthetic mechanisms. Later, various biological activities were demonstrated through in vitro and in vivo studies, including anti-inflammatory, antimicrobial, antioxidant, antiproliferative, and neuroprotective properties, with notable effects on bone metabolism. Recent progress has been made in developing synthetic routes for obtaining medicarpin and in analytical methods for its analysis and quantification. Studies on preclinical pharmacokinetics and advances in alternative synthesis of medicarpin are at the forefront of current research. Advancements in stability, toxicity, pharmaceutical technologies in formulations, and potential clinical applications are necessary but remain challenging. This review aims to provide critical insights and compile the main botanical, chemical, and therapeutic aspects of medicarpin, as well as the challenges and perspectives for the biomedical and pharmaceutical fields.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research